Toxicity and Efficacy of ≥4th Line Palbociclib with Endocrine Therapy of Physician's Choice: a Single Centre Experience. Issue 6 (June 2017) - Kingston, B.; Charbouni, N.; Doody, C.; Irfan, T.; Okines, A.; Johnston, S.